Invitation to First-Half 2026 webcast - Thursday 27 August 2026

Oslo, Norway, 17 August 2026 - Oncoinvent ASA (ONCIN), a biotech company developing a receptor-independent alpha radiopharmaceutical to eradicate cancer cells in the abdominal cavity after surgery with a single, targeted dose, is pleased to invite investors, analysts, and stakeholders to a live webcast event at 10:00 a.m. CET on Thursday, 27 August 2026.

• Date: Thursday, 27 August 2026
• Time: 10:00 a.m. CET
• Webcast link: https://qcnl.tv/p/FlGvKEVec2WWcnTYYHBK4g   

The First-Half 2026 Report and Presentation will be made available in the Investors section of the Company's website at www.oncoinvent.com at 07:00 a.m. CET. A recording of the webcast will be made available following the live webcast.

Oncoinvent reports its financial results on a half-yearly basis, complemented by quarterly business updates to keep stakeholders informed and ensure ongoing transparency.